Immunogenicity of repeat COVID-19 mRNA vaccinations in a patient with myasthenia gravis receiving mycophenolate, prednisone, and eculizumab

Vaccination can prevent infection and disease due to SARS-CoV-2. Early reports indicate that immune suppressed or immune compromised populations have reduced immune responses to US emergency use authorized (EUA) vaccines. Patients with autoimmune disorders are at risk for severe COVID-19, and are fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Plymate, Lisa C., Pepper, Gregory, Krist, Maxwell P., Koelle, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375276/
https://www.ncbi.nlm.nih.gov/pubmed/34426798
http://dx.doi.org/10.1016/j.jtauto.2021.100114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375276/
https://www.ncbi.nlm.nih.gov/pubmed/34426798
http://dx.doi.org/10.1016/j.jtauto.2021.100114

Ejemplares similares